Respirix
San Francisco, US · Founded 2015 · Delaware corporation
Founders & leadership
EK
Eric KriegsteinNamed on SEC filing
EL
Evan LuxonNamed on SEC filing
DB
Daniel BurnettNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.3M disclosed across 1 round · 2018
▶$1.3MraisedAug 2019 · 90 investors · Other Health CareRule 506(c)
▶$1.3MraisedAug 2019 · 90 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Eric KriegsteinExecutive Officer, Director
- Evan LuxonExecutive Officer, Director
- Daniel BurnettExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.3M
- Minimum investment
- $200
- Sales commissions
- $47.3K
- Placement agents
- SI Securities, LLC
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- How much funding has Respirix raised?
- Respirix has disclosed $1.3M raised across 1 round.
- Where is Respirix headquartered?
- Respirix is headquartered in San Francisco, US.